Patients with Parkinsons disease (PD) are known to suffer from motor symptoms of the disease, but they also experience non-motor symptoms (NMS) that are often present before diagnosis or that inevitably emerge with disease progression. The motor symptoms of Parkinsons disease have been extensively researched, and effective clinical tools for their assessment and treatment have been developed and are readily available. In contrast, researchers have only recently begun to focus onthe NMS of Parkinsons Disease, which are poorly recognized and inadequately treated by clinicians.The NMS of PD have a significant impact on patient quality of life and mortality and include neuropsychiatric, sleep-related, autonomic, gastrointestinal, and sensory symptoms. While some NMS can be improved with currently available treatments, others may be more refractory and will require research into novel (non-dopaminergic) drug therapies for the future.Edited by members of the UK Parkinsons Disease Non-Motor Group (PD-NMG) and with contributions from international experts, this new edition summarizes the current understanding of NMS symptoms in Parkinsons disease and points the way towards future research.
Section 1 NMS: General concepts; What are the non-motor symptoms of Parkinsons disease?; Non-motor symptoms and pre-motor diagnosis of Parkinsons disease; Non-motor symptoms in the early motor stages of Parkinsons disease; Non-motor symptoms in advanced Parkinsons disease; Assessment tools for non-motor symptoms of Parkinsons disease in the clinical setting; Imaging non-motor aspects of Parkinsons disease; Non-motor signs in genetic forms of Parkinsons disease; Section 2: Specific NMS of PD; Cognitive dysfunction of Parkinsons disease; Depression, anxiety and apathy in Parkinsons disease; Dementia in Parkinsons disease; Fatigue in Parkinsons disease; Psychosis in Parkinsons disease; Neurobiology of sleep: The role of dopamine in Parkinsons disease related sleep disorders; REM sleep behaviour disorder in Parkinsons disease; Parkinsons disease and restless legs syndrome; Excessive daytime sleepiness in Parkinsons disease; Bladder dysfunction in Parkinsons disease; Sexuality in Parkinsons disease; Gastrointestinal dysfunctions in Parkinsons disease; Postural hypotension in Parkinsons disease; Sialorrhoea in Parkinsons disease; Olfaction in Parkinsons disease; Chronic pain and Parkinsons disease; Visual function in Parkinsons disease; Section 3: Quality of Life, Comorbidity, drug effects and surgery; Non-motor symptoms and health-related quality of life: an overview; Non motor symptoms and co-morbidity in Parkinsons disease; Non-motor symptoms of Parkinsons disease and the effects of deep brain stimulation surgery; Impulse dyscontrol and dopamine dysregulation syndrome; Treatment-related non-motor symptoms in Parkinsons disease; Thermoregulatory dysfunction in Parkinsons disease; The role of continuous dopaminergic stimulation in the management of non-motor symptoms in Parkinsons disease;
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.